Interindividual variability and its impact on the effectiveness of Janus kinase inhibitors in rheumatoid arthritis treatment

IntroductionAchieving the primary treat-to-target (T2T) goal in rheumatoid arthritis (RA) remains challenging for many patients, reflecting limitations in the effectiveness of existing treatments. Our study examines factors influencing Janus kinase (JAK) inhibitor effectiveness by analyzing interind...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Cristina Martinez-Molina, Silvia Vidal, Cesar Diaz-Torne, Hye S. Park, Hèctor Corominas
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2025-03-01
Saila:	Frontiers in Medicine
Gaiak:	Janus kinase inhibitor tofacitinib baricitinib upadacitinib filgotinib treatment effectiveness
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1512501/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!